Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies (Q33422320)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies |
scientific article |
Statements
1 reference
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies (English)
1 reference
Kensei Tobinai
1 reference
Kiyohiko Hatake
1 reference
Michinori Ogura
1 reference
Toshiki Uchida
1 reference
Yasuhito Terui
1 reference
Fumihiko Hayakawa
1 reference
Masafumi Taniwaki
1 reference
Yasushi Takamatsu
1 reference
Tomoki Naoe
1 reference
Wataru Munakata
1 reference
Takeshi Yamauchi
1 reference
Akiko Kageyama
1 reference
Miyuki Yuasa
1 reference
Masaaki Motoyama
1 reference
Takeshi Tsunoda
1 reference
25 May 2015
1 reference
1 reference
106
1 reference
896-901
1 reference
Identifiers
1 reference
1 reference
1 reference